Chinese cancer detection firm Burning Rock eyes US IPO
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings
Asia

Chinese cancer detection firm Burning Rock eyes US IPO

Jonathan Breen
May 25, 2020 09:15 AM
Pharma_drugs_adobe_575x375.jpg

Burning Rock Biotech is planning to float on Nasdaq for as much as $100m.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsEquityChina Merchants Bank CoChinaBank of AmericaAmericasAsiaGreater ChinaMorgan StanleyNortheast AsiaAsia PacificUnited StatesEmerging MarketsNorth America
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article